Neo Ivy Capital Management Insulet Corp Transaction History
Neo Ivy Capital Management
- $505 Million
- Q2 2024
A detailed history of Neo Ivy Capital Management transactions in Insulet Corp stock. As of the latest transaction made, Neo Ivy Capital Management holds 524 shares of PODD stock, worth $121,961. This represents 0.02% of its overall portfolio holdings.
Number of Shares
524Holding current value
$121,961% of portfolio
0.02%Shares
13 transactions
Others Institutions Holding PODD
# of Institutions
659Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.96 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.66 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.41 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$665 Million0.03% of portfolio
-
Baillie Gifford & CO1.89MShares$439 Million0.3% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $16.2B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...